Over-expression of hybrid IGF1R and IR-A receptors has been reported in breast cancer [23], but owing to technical difficulties in quantifying IR-A and IR-B in large numbers of clinical samples, the overall expression levels of IR-A and IR-B in breast cancer relative to normal breast tissue were not fully known. The gene discussed is IGF1R; the disease is breast carcinoma.